Home › Retinoblastoma › NCT04959097
Retinoblastoma Patient Clinical Database and Tissue Repository
RecruitingObservational study
Who can join
Ages 0 to 18 · All sexes
Full eligibility criteria
Inclusion Criteria: * All patients, age 0 days to 18 years, with a diagnosis unilateral or bilateral retinoblastoma (RB) seen at CHLA (Children's Hospital Los Angeles). Exclusion Criteria: * Patients referred for second opinions only and not treated at CHLA for any reason.
About the study
Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed.
Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.
Sponsor: Children's Hospital Los Angeles · Participants: 800 · Started: Jan 1, 2017
Contact the study team
- Jesse L Berry, MD · Phone: 323-361-4510
Official record on ClinicalTrials.gov — NCT04959097
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.